Internal Server Error

Aaron Vandevender - portfolio and founded companies

Last updated:

About Aaron Vandevender

Aaron Vandevender is an entrepreneur, an angel investor and a board member based out of San Francisco, United States. They did their Bachelors from MIT in 2001. Their journey in the startup ecosystem started in 2010 through Methid. Aaron Vandevender has founded 1 company. They are currently acting as the founder of Methid. As an angel investor, Aaron Vandevender has a portfolio of 1 company, focusing primarily on sectors like Enterprise Applications, High Tech and 2 more sectors. They invest in companies across United States. Their most notable investment is IDPartner. Aaron Vandevender is currently serving as a board member at Emulate and Modumetal.
Key Metrics
Location
San Francisco, United States
Founded
Board Memberships
Investment Portfolio
Top sectors of Investment
Top locations of Investment
Contact Details

Aaron Vandevender's Investments

Aaron Vandevender has invested in 1 company, which was in IDPartner (Seed Round) on Apr 26, 2023. Their investments are primarily in Enterprise Applications, High Tech and 2 more sectors. Their investment portfolio companies are located in United States.
Here is the detail of this recent investment:
Date
Company
Round
Round Amount
Co-Investors
Apr 26, 2023
Seed
$3.1M
View all Investments by Aaron Vandevender
Want to explore profiles similar to Aaron Vandevender?
Let us walk you through our investor database and other offerings.

Aaron Vandevender's Founded Companies

Aaron Vandevender has founded Methid.
Here is the detail of this founded company:
Company
Short Description
Total Funding
Founded Year
Current Stage
Location
Provider of AI-based automation platform for research and drug discovery
-
2010
Unfunded
San Francisco
View all Founded Companies by Aaron Vandevender

Aaron Vandevender's Board Memberships

Aaron Vandevender has 2 current board memberships namely Emulate and Modumetal.
Here are the details of all board memberships by Aaron Vandevender:
Company
Description
Total Funding
Current Stage
Membership Status
Appointment Date
Cessation Date
Developer of in vitro models for drug development
$204M
Series E
CURRENT
Jun 21, 2018
-
Developer of nanolaminated materials designed to improve the performance of metals
$107M
Series A
CURRENT
Jun 08, 2015
-
View all Board Memberships of Aaron Vandevender

FAQs about Aaron Vandevender

Recently updated other profiles
Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford